Association between endothelial nitric oxide synthase (NOS3) rs2070744 and the risk for migraine

Article metrics

  • 6 Accesses

Abstract

Because nitric oxide could play an important role in the pathogenesis of migraine (suggested by experimental, neuropathological, biochemical, and pharmacological data), and a recent meta-analysis showed an association between the single-nucleotide polymorphism (SNP) rs2070744 in the endothelial nitric oxide synthase (eNOS or NOS3) gene (chromosome 7q36.1) and the risk for migraine in Caucasians, we attempted to replicate the possible association between this SNP and the and the risk for migraine in the Caucasian Spanish population. The frequencies for the NOS3 rs2070744 genotypes and allelic variants were assessed in 283 migraine patients and 287 healthy controls with a TaqMan-based qPCR Assay. The putative influence on genotype frequency of age at onset of migraine attacks, gender, family history of migraine, absence or presence of aura, and triggering of migraine attacks by ethanol, were also analyzed. The frequencies of NOS3 rs2070744 genotypes and allelic variants were not associated with the risk for migraine (OR [95%] CI for the minor allele = 0.91 [0.72–1.15]) and were not influenced by age at onset of migraine, gender, presence of aura, or triggering of migraine attacks by ethanol. NOS3 rs2070744CC genotypes were significantly more frequent in patients with a family history of migraine. NOS3 rs2070744 SNP is not associated with the risk for migraine in Caucasian Spanish people although it might be related to family history.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Mateos V, Pareja JA, Pascual J. Tratado de cefaleas. Madrid: Luzán 5 S.A. Ediciones; 2009.

  2. 2.

    Gormley P, Anttila V, Winsvold BS, Palta P, Esko T, Pers TH, et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016;48:856–66.

  3. 3.

    Molina JA, Jiménez-Jiménez FJ, Ortí-Pareja M, Navarro JA. The role of nitric oxide in neurodegeneration: potential for pharmacological intervention. Drugs Aging. 1998;12:251–9.

  4. 4.

    García-Martín E, Martínez C, Serrador M, Alonso-Navarro H, Navacerrada F, García-Albea E, et al. Neuronal nitric oxide synthase (nNOS, NOS1) rs693534 and rs7977109 variants and risk for migraine. Headache. 2015;55:1209–17.

  5. 5.

    Pradhan AA, Bertels Z, Akerman S. Targeted nitric oxide synthase inhibitors for migraine. Neurotherapeutics. 2018;15:391–401.

  6. 6.

    Griffiths LR, Nyholt DR, Curtain RP, Goadsby PJ, Brimage PJ. Migraine association and linkage studies of an endothelial nitric oxide synthase (NOS3) gene polymorphism. Neurology. 1997;49:614–7.

  7. 7.

    Lea RA, Curtain RP, Shepherd AG, Brimage PJ, Griffiths LR. No evidence for involvement of the human inducible nitric oxide synthase (iNOS) gene in susceptibility to typical migraine. Am J Med Genet. 2001;105:110–3.

  8. 8.

    Logan JF, Chakravarthy U, Hughes AE, Patterson CC, Jackson JA, Rankin SJ. Evidence for association of endothelial nitric oxide synthase gene in subjects with glaucoma and a history of migraine. Investig Ophthalmol Vis Sci. 2005;46:3221–6.

  9. 9.

    Borroni B, Rao R, Liberini P, Venturelli E, Cossandi M, Archetti S, et al. Endothelial nitric oxide synthase (Glu298Asp) polymorphism is an independent risk factor for migraine with aura. Headache. 2006;46:1575–9.

  10. 10.

    Toriello M, Oterino A, Pascual J, Castillo J, Colás R, Alonso-Arranz A, et al. Lack of association of endothelial nitric oxide synthase polymorphisms and migraine. Headache. 2008;48:1115–9.

  11. 11.

    Schürks M, Kurth T, Buring JE, Zee RY. A candidate gene association study of 77 polymorphisms in migraine. J Pain. 2009;10:759–66.

  12. 12.

    Jia S, Ni J, Chen S, Jiang Y, Dong W, Gao Y. Association of the pentanucleotide repeat polymorphism in NOS2 promoter region with susceptibility to migraine in a Chinese population. DNA Cell Biol. 2011;30:117–22.

  13. 13.

    Gonçalves FM, Martins-Oliveira A, Speciali JG, Luizon MR, Izidoro-Toledo TC, Silva PS, et al. Endothelial nitric oxide synthase haplotypes associated with aura in patients with migraine. DNA Cell Biol. 2011;30:363–9.

  14. 14.

    de OS, Mansur T, Gonçalves FM, Martins-Oliveira A, Speciali JG, Dach F, et al. Inducible nitric oxide synthase haplotype associated with migraine and aura. Mol Cell Biochem. 2012;364:303–8.

  15. 15.

    Gonçalves FM, Luizon MR, Speciali JG, Martins-Oliveira A, Dach F, Tanus-Santos JE. Interaction among nitric oxide (NO)-related genes in migraine susceptibility. Mol Cell Biochem. 2012;370:183–9.

  16. 16.

    Alaşehirli B, Akçalı A, Demiryürek AT, Özel A, Erdal ME, Neyal M. Lack of association between the C276T polymorphism of the neuronal nitric oxide synthase gene and migraine. Int J Neurosci. 2013;123:50–4.

  17. 17.

    Eröz R, Bahadir A, Dikici S, Tasdemir S. Association of endothelial nitric oxide synthase gene polymorphisms (894G/T, -786T/C, G10T) and clinical findings in patients with migraine. Neuromolecular Med. 2014;16:587–93.

  18. 18.

    Güler S, Gürkan H, Tozkir H, Turan N, Çelik Y. An investigation of the relationship between the eNOS gene polymorphism and diagnosed migraine. Balk J Med Genet. 2015;17:49–59.

  19. 19.

    Zakerjafari M, Dehkordi FF, Yaghoubi H. Evaluation of NOS3 T-C 786 gene polymorphism in Iranian patients affected by migraine and normal individuals. Adv Biores. 2016;7:16–9.

  20. 20.

    Dong H, Wang ZH, Dong B, Hu YN, Zhao HY. Endothelial nitric oxide synthase (-786T>C) polymorphism and migraine susceptibility: a meta-analysis. Medicine. 2018;97:e12241.

  21. 21.

    Headache Classification Committee of the International Headache Society. The International classification of headache disorders, 2nd ed. Cephalalgia. 2004;24(Suppl.1):1–160.

  22. 22.

    García-Martín E, Martínez C, Serrador M, Alonso-Navarro H, Navacerrada F, Agúndez JA, et al. Histamine-N-methyl transferase polymorphism and risk for migraine. Headache. 2008;48:1343–8.

  23. 23.

    García-Martín E, Martínez C, Serrador M, Alonso-Navarro H, Navacerrada F, Agúndez JA, et al. Alcohol dehydrogenase 2 genotype and risk for migraine. Headache. 2010;50:85–91.

  24. 24.

    García-Martín E, Martínez C, Serrador M, Alonso-Navarro H, Navacerrada F, Agúndez JA, et al. Dopamine receptor 3 (DRD3) polymorphism and risk for migraine. Eur J Neurol. 2010;17:1220–3.

  25. 25.

    García-Martín E, Martínez C, Serrador M, Alonso-Navarro H, Navacerrada F, Agúndez JA, et al. Paraoxonase 1 (PON 1) polymorphisms and risk for migraine. J Neurol. 2010;257:1482–5.

  26. 26.

    García-Martín E, Martínez C, Serrador M, Alonso-Navarro H, Navacerrada F, Agúndez JA, et al. SLC1A2 rs3794087 variant and risk for migraine. J Neurol Sci. 2014;338:92–5.

  27. 27.

    García-Martín E, Martínez C, Serrador M, Alonso-Navarro H, Ayuso P, Navacerrada F, et al. Diamine oxidasers10156191 and rs2052129 variants are associated with the risk for migraine. Headache. 2015;55:276–86.

  28. 28.

    García-Martín E, Martínez C, Serrador M, Alonso-Navarro H, Navacerrada F, Esguevillas G, et al. Gamma-aminobutyric acid (Gaba) receptors Rho (Gabrr) gene polymorphisms and risk for migraine. Headache. 2017;57:1118–35.

  29. 29.

    García-Martín E, Esguevillas G, Serrador M, Alonso-Navarro H, Navacerrada F, Amo G, et al. Gamma-aminobutyric acid (GABA) receptors GABRA4, GABRE, and GABRQ gene polymorphisms and risk for migraine. J Neural Transm. 2018;125:689–98.

  30. 30.

    Altman DG, Bland JM. Diagnostic tests 2: predictive values. Brit Med J. 1994;309:102.

  31. 31.

    Napoli C, Ignarro LJ. Nitric oxide and atherosclerosis. Nitric Oxide. 2001;5:88–97.

  32. 32.

    Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro LJ. Nitric oxide and atherosclerosis: an update. Nitric Oxide. 2006;15:265–79.

  33. 33.

    Kong XZ, Zhang ZY, Wei LH, Li R, Yu J. The endothelial nitric oxide synthase gene T-786C polymorphism increases myocardial infarction risk: a meta-analysis. Med Sci Monit. 2017;23:759–66.

  34. 34.

    Dong J, Ping Y, Wang Y, Zhang Y. The roles of endothelial nitric oxide synthase gene polymorphisms in diabetes mellitus and its associated vascular complications: a systematic review and meta-analysis. Endocrine. 2018;62:412–22.

  35. 35.

    Li X, Lin Y, Zhang R. Associations between endothelial nitric oxide synthase gene polymorphisms and the risk of coronary artery disease: a systematic review and meta-analysis of 132 case-control studies. Eur J Prev Cardiol. 2019;26:160–70.

  36. 36.

    Gamil S, Erdmann J, Abdalrahman IB, Mohamed AO. Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study. BMC Med Genet. 2017;18:128.

  37. 37.

    Midani F, Ben Amor Z, El Afrit MA, Kallel A, Feki M, Soualmia H. The role of genetic variants (rs869109213 and rs2070744) of the eNOS gene and BglII in the α2 subunit of the α2β1 integrin gene in diabetic retinopathy in a Tunisian population. Semin Ophthalmol. 2019;34:365–74.

  38. 38.

    Nan J, Liu Y, Xu C, Ge D. Effects of eNOS gene polymorphisms on individual susceptibility to cancer: a meta-analysis. Nitric Oxide. 2019;84:1–6.

  39. 39.

    Mazurek-Mochol M, Kozak M, Sawczuk M, Maciejewska A, Malinowski D, Safranow K, et al. Nos3 gene Rs1799983 and Rs2070744 polymorphisms in patients with periodontal disease. Folia Biol. 2018;64:59–64.

  40. 40.

    Zhou L, Hui X, Yuan H, Liu Y, Wang Y. Combination of genetic markers and age effectively facilitates the identification of people with high risk of preeclampsia in the Han Chinese population. Biomed Res Int. 2018;2018:4808046.

  41. 41.

    Jeoung JW, Kim DM, Oh S, Lee JS, Park SS, Kim JY. The relation between endothelial nitric oxide synthase polymorphisms and normal tension glaucoma. J Glaucoma. 2017;26:1030–5.

  42. 42.

    Coto-Segura P, Coto E, Mas-Vidal A, Morales B, Alvarez V, Díaz M, et al. Influence of endothelial nitric oxide synthase polymorphisms in psoriasis risk. Arch Dermatol Res. 2011;303:445–9.

  43. 43.

    Heidari MM, Khatami M, Tahamtan Y. Molecular analysis of rs2070744 and rs1799983 polymorphisms of NOS3 gene in Iranian patients with multiple sclerosis. Basic Clin Neurosci. 2017;8:279–84.

  44. 44.

    Wu Y, Zhu Z, Fang X, Yin L, Liu Y, Xu S, et al. The association between NOS3 gene polymorphisms and hypoxic-ischemic encephalopathy susceptibility and symptoms in Chinese Han population. Biomed Res Int. 2016;2016:1957374.

  45. 45.

    Hendrix P, Foreman PM, Harrigan MR, Fisher WS 3rd, Vyas NA, Lipsky RH, et al. Endothelial nitric oxide synthase polymorphism is associated with delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage. World Neurosurg. 2017;101:514–9.

  46. 46.

    Gómez-Gallego F, Ruiz JR, Buxens A, Artieda M, Arteta D, Santiago C, et al. The -786 T/C polymorphism in the NOS3 gene is associated with elite performance in power sports. Eur J Appl Physiol. 2009;107:565–9.

  47. 47.

    Zmijewski P, Cięszczyk P, Ahmetov II, Gronek P, Lulińska-Kuklik E, Dornowski M, et al. The NOS3 G894T (rs1799983) and -786T/C (rs2070744) polymorphisms are associated with elite swimmer status. Biol Sport. 2018;35:313–9.

  48. 48.

    Weyerstraß J, Stewart K, Wesselius A, Zeegers M. Nine genetic polymorphisms associated with power athlete status – a meta-analysis. J Sci Med Sport. 2018;21:213–20.

  49. 49.

    Fan AZ, Fang J, Yesupriya A, Chang MH, Kilmer G, House M, et al. Gene polymorphisms in association with self-reported stroke in US adults. Appl Clin Genet. 2010;3:23–28.

  50. 50.

    Anlıaçık SÖ, Tokgöz S, Zamani AG, Yıldırım MS, İyisoy MS. Investigation of the relationship between ischemic stroke and endothelial nitric oxide synthase gene polymorphisms [G894T, intron 4 VNTR and T786C]. Turk J Med Sci. 2019;49:589–94.

  51. 51.

    Gao J, Wang M, Wei L, Niu D, Wei J, Ou Y, et al. The endothelial nitric oxide synthase gene polymorphism is associated with the susceptibility to immunoglobulin a nephropathy in Chinese population. Kidney Blood Press Res. 2017;42:608–16.

Download references

Acknowledgements

This work was supported in part by grants RETICS RD16/0006/0004 (ARADyAL), PI15/00303, and PI18/00540 from Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Madrid, Spain, and GR18145 and IB16170 from Junta de Extremadura, Mérida, Spain. Partially funded with FEDER funds.

Author information

Correspondence to Félix Javier Jiménez-Jiménez.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

García-Martín, E., Navarro-Muñoz, S., Rodriguez, C. et al. Association between endothelial nitric oxide synthase (NOS3) rs2070744 and the risk for migraine. Pharmacogenomics J (2019) doi:10.1038/s41397-019-0133-x

Download citation